Concepedia

Manu Pandey

MP

Statistics

Publications

7

Citations

301

H-Index

7

Active since

2017

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Manu Pandey is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, oncology, and immunotherapy.

ORCID

Publications per year

2017–2024

7

Publications

7

Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

Shipra Gandhi, Manu Pandey, Kristopher Attwood et al. · Clinical Cancer Research · 2020 · 144 citations · Full text

, , +17

Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies

Saeed Daneshmandi, Jee Eun Choi, Yan Qi et al. · Nature Communications · 2024 · 36 citations · Full text

, , +12

Impact of Concomitant Medication Use and Immune-Related Adverse Events on Response to Immune Checkpoint Inhibitors

Shipra Gandhi, Manu Pandey, Nischala Ammannagari et al. · Immunotherapy · 2020 · 33 citations · Full text

, , +15

Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors

Ahmad Hanif, Manu Pandey, Sumera Khan et al. · OncoImmunology · 2019 · 27 citations · Full text

, , +14

Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy

Jurjen Versluis, Manu Pandey, Yael Flamand et al. · Blood Advances · 2022 · 25 citations · Full text

, , +13

1–5 of 7